✦ LIBER ✦

Impaired CD4+ cell recovery during antiretroviral therapy in patients with HIV resistance mutations

✍ Scribed by Kurt-Wolfram Sühs; M. Stoll; R. Diem; R. E. Schmidt; H. Heiken

Book ID: 106212052
Publisher: Springer Vienna
Year: 2011
Tongue: English
Weight: 291 KB
Volume: 157
Category: Article
ISSN: 1432-8798
DOI: 10.1007/s00705-011-1191-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CD4+ Lymphocyte Increases in HIV Patient

CD4+ Lymphocyte Increases in HIV Patients during Potent Antiretroviral Therapy Are Dependent on Inhibition of CD8+ Cell Apoptosis

✍ SANDRO GRELLI; GABRIELLA D'ETTORE; FILIPPO LAURIA; FRANCESCO MONTELLA; LOIDE DI 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 907 KB

Could natural killer cells compensate fo

Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?

✍ Dino Bee Aik Tan; Sonia Fernandez; Martyn French; Patricia Price 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 570 KB

T cell apoptosis in HIV-infected patient

T cell apoptosis in HIV-infected patients with incomplete immune recovery after antiretroviral therapy

✍ E. V. Saidakova, L. B. Korolevskaya, N. G. Shmagel, K. V. Shmagel, V. A. Cheresh 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 105 KB

Mutations associated with genotypic resi

Mutations associated with genotypic resistance to antiretroviral therapy in treatment naı̈ve HIV-1 infected patients in Greece

✍ E. Magiorkinis; D. Paraskevis; G. Magiorkinis; S. Chryssou; M. Chini; M. Lazanas 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Progressive Reduction of CMV-Specific CD

Progressive Reduction of CMV-Specific CD4+ T Cells in HIV-1 Infected Individuals During Antiretroviral Therapy

✍ Volker Grosse; Alexander Schulte; Klaus Weber; Myriam Mendila; Roland Jacobs; Re 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 615 KB

Failure of stavudine-lamivudine combinat

Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-Like HIV-1 resistance mutations

✍ Loredana Sarmati; Emanuele Nicastri; Saverio Giuseppe Parisi; Gabriella D'Ettorr 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

## Abstract To analyze the clinical relevance of AZT resistance mutations in AZT‐naive patients, 56 HIV‐1 seropositive patients treated for 18 months with stavudine/lamivudine (27 patients) or AZT/lamivudine (29 patients) were studied. AZT‐like resistance mutations were found in 13 out of 29 (44%)